LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1433 | 4267 | 0.3365 | 0.0872 |
MCF7 | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3789 | 4267 | 0.8882 | 0.8715 |
MCF7 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4211 | 4267 | 0.9887 | 0.9876 |
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 777 | 4267 | 0.1822 | -0.2286 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4851 | 4267 | 1.1371 | 1.1490 |
MCF7 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4537 | 4267 | 1.0633 | 1.0695 |
MCF7 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4829 | 4267 | 1.1306 | 1.1406 |
MCF7 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4687 | 4267 | 1.0985 | 1.1079 |
MCF7 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4230 | 4267 | 0.9910 | 0.9888 |
MCF7 | CP466722 | 10 | uM | LJP5 | 72 | hr | 1235 | 1972 | 4267 | 0.4623 | 0.2987 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3247 | 4267 | 0.7619 | 0.7178 |
MCF7 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3363 | 4267 | 0.7888 | 0.7515 |
MCF7 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3410 | 4267 | 0.7997 | 0.7651 |
MCF7 | CP724714 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3304 | 4267 | 0.7743 | 0.7334 |
MCF7 | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 3278 | 4267 | 0.7684 | 0.7259 |
MCF7 | CP724714 | 10 | uM | LJP5 | 72 | hr | 1235 | 2110 | 4267 | 0.4950 | 0.3495 |
MCF7 | HG-5-113-01 | 10 | uM | LJP5 | 72 | hr | 1235 | 883 | 4267 | 0.2073 | -0.1712 |
MCF7 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2689 | 4267 | 0.6306 | 0.5451 |
MCF7 | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2436 | 4267 | 0.5710 | 0.4617 |
MCF7 | Neratinib | 10 | uM | LJP5 | 72 | hr | 1235 | 1169 | 4267 | 0.2741 | -0.0312 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2621 | 4267 | 0.6157 | 0.5235 |
MCF7 | Seliciclib | 10 | uM | LJP5 | 72 | hr | 1235 | 706 | 4267 | 0.1657 | -0.2687 |
MCF7 | Dasatinib | 10 | uM | LJP5 | 72 | hr | 1235 | 918 | 4267 | 0.2150 | -0.1538 |
MCF7 | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3061 | 4267 | 0.7180 | 0.6618 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3325 | 4267 | 0.7794 | 0.7387 |